Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Up to half of patients with Graves' hyperthyroidism have signs of thyroid associated ophthalmopathy, but the factors that cause this disorder are unknown. We investigated two major genetic susceptibility loci for Graves' disease in ophthalmopathy; the MHC class II region and the cytotoxic T lymphocyte antigen-4 (CTLA4) gene. Allelic frequencies of these genes in patients with Graves' disease who did and did not have concurrent thyroid-associated ophthalmopathy did not differ, and are, therefore, unlikely to contribute to its development.

Type

Journal article

Journal

Lancet

Publication Date

22/09/2001

Volume

358

Pages

984 - 985

Keywords

Abatacept, Adult, Alleles, Antigens, CD, Antigens, Differentiation, CTLA-4 Antigen, Case-Control Studies, Female, Genes, MHC Class II, Genetic Predisposition to Disease, Genotype, Graves Disease, Humans, Immunoconjugates, Logistic Models, Male, Smoking